肝细胞癌中的长非编码RNA:机械学见解和治疗前景
Kexin Yu1,2, Yuanxiang Jin1, Yidong Zhou1
1Fourth Clinical Medical College of Zhejiang Chinese Medical University, Affiliated Hangzhou First People's Hostipal, Hangzhou, 310053, China.
Cellular oncology (Dordrecht, Netherlands)
|November 4, 2025
概括
长非编码RNAs (lncRNAs) 在肝细胞癌 (HCC) 的发展和进展中至关重要. 这篇评论详细介绍了 lncRNAs.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- HCC的发病过程涉及复杂的机制,包括DNA损伤和表观遗传变化.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是它们在HCC中的作用.
研究的目的:
- 阐明 lncRNAs 在 HCC 中的致病作用.
- 总结IncRNA合成机制和HCC中的调控功能.
- 探索 lncRNAs作为潜在的生物标志物和HCC的治疗点.
主要方法:
- 对HCC中的lncRNA研究的文献综述.
- 对lncRNA参与基因表达,转录和mRNA稳定性的分析.
- 在HCC中识别特定的lncRNA及其相关信号通路.
主要成果:
- 特定的lncRNAs (例如,NEAT1,HULC,HOTAIR) 影响HCC细胞的增殖,迁移和亡.
- 其他lncRNAs (例如,LINC01343,FAM111A-DT) 显著影响HCC进展和患者预后.
- 一些lncRNAs (例如,MIR31HG,CASC2c) 显示出作为治疗点的潜力.
结论:
- lncRNAs在HCC的发展和进展中发挥着多方面的作用.
- lncRNAs调节HCC中的关键细胞过程和信号通路.
- lncRNAs代表了对HCC管理的有前途的生物标志物和治疗点.
更多相关视频
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
1.0K
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
9.4K
相关概念视频
lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
lncRNA - Long Non-coding RNAs
3.4K
3.4K
Types of RNA
8.8K
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
RNA Performs Diverse...
8.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
